MedTrace Logo

the Dutch-GERAF Study

NCT05337202 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1075

Last updated 2024-02-20

No results posted yet for this study

Summary

Geriatric patients are at high risk of cardiovascular complications, and for the development of atrial fibrillation. Often atrial fibrillation exists in these patients without specific symptoms, and could therefore remain unknown. Furthermore, concerns exist about the bleeding profile of anticoagulation in the very elderly or frail patients.

This study applies opportunistic screening for atrial fibrillation as advised in the latest ESC Guideline on the diagnosis and management of atrial fibrillation. Furthermore, multiple bleeding risk scores will be applies, to better assess the bleeding risk in very elderly or frail patients.

Conditions

Interventions

DEVICE

HeartSDK

The photoplethysmography (PPG) application enables patients to perform a finger tip heartbeat measurement and automatic analysis

Sponsors & Collaborators

  • Dijklander Ziekenhuis

    lead OTHER

Principal Investigators

  • René Jansen, PhD · Northwest Hospital

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-25
Primary Completion
2022-10-26
Completion
2026-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05337202 on ClinicalTrials.gov